Rubius Therapeutics to Participate in 7th Annual Jefferies Cell Therapy Summit

Rhea-AI Summary

Rubius Therapeutics (Nasdaq: RUBY) announced that Laurence Turka, M.D., chief scientific officer, will participate in a fireside chat at the 7th Annual Jefferies Cell Therapy Summit on October 5, 2020, at 4:00 p.m. ET. The event will feature a live audio webcast available on the company's website, with an archived replay accessible for 90 days. Rubius is focused on developing Red Cell Therapeutics™ for cancer and autoimmune diseases.

CAMBRIDGE, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, today announced that Laurence Turka, M.D., chief scientific officer, will participate in a fireside chat at the 7th Annual Jefferies Cell Therapy Summit on Monday, October 5, 2020, at 4:00 p.m. ET.

A live audio webcast will be available on the Events and Presentations page within the Investors and Media section of the Rubius Therapeutics website. An archived replay will be accessible for 90 days following the event.

About Rubius Therapeutics

Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The Company’s proprietary RED PLATFORM^® was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Rubius’ initial focus is to advance RCT™ product candidates for the treatment of cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. For more information, visit www.rubiustx.com, follow us on Twitter or LinkedIn or like us on Facebook.

Contacts:

Investors
Lori Melançon
Vice President, Corporate Communications and Investor Relations
+1 (617) 949-5296
lori.melancon@rubiustx.com

Media 
Marissa Hanify
Director, Corporate Communications
marissa.hanify@rubiustx.com

Dan Budwick
1AB
+1 (973) 271-6085
dan@1abmedia.com

FAQ

What is the date and time of Rubius Therapeutics' presentation at the Jefferies Cell Therapy Summit?

Rubius Therapeutics will present on October 5, 2020, at 4:00 p.m. ET.

Where can I watch the Rubius Therapeutics presentation live?

The live audio webcast can be accessed on the Rubius Therapeutics website under the Events and Presentations section.

How long will the Rubius Therapeutics presentation be available for replay?

The archived replay of the presentation will be available for 90 days following the event.

What is Rubius Therapeutics focusing on in terms of treatment?

Rubius Therapeutics is focused on developing Red Cell Therapeutics™ to treat cancer and autoimmune diseases.

What is the stock symbol for Rubius Therapeutics?

The stock symbol for Rubius Therapeutics is RUBY.